Sepracor (SEPR) option implied volatility at 48
More News related to SEPR
- Dainippon Sumitomo Pharma Co., Ltd. Completes Acquisition of Sepracor Inc.
- Dainippon Sumitomo Pharma Co., Ltd. and Sepracor Inc. Announce Completion of Subsequent Offering Period and Exercise of Top-Up Option
- Dainippon Sumitomo Pharma Co., Ltd. and Sepracor Inc. Announce Successful Tender Offer and Commencement of Subsequent Offering Period
- S&P Announces Changes to US Indices: ATO for SEPR, MNRO for ATO, USMO for CACB, BJRI for FTBK
- Standard & Poor's Announces Changes to U.S. Indices
More News related to Analyst Comments
- Goldman Sachs Added Cytec Industries (CYT) to their Conviction Sell List
- FBR Capital Recommends An IPO or Spin Off at Chesapeake Energy (CHK)
- Canaccord Adams Maintains a 'Buy' on Silver Wheaton (SLW); Raises Price Target
- Citi Boosts Target on McDonald's (MCD) to $64, Maintains Hold
- Canaccord Adams Reiterates a 'Buy' on Veeco Instruments (VECO); Raises PT & Estimates
Sepracor (Nasdaq: SEPR) : SEPR closed at $52.47. SBSH says "medicare's bill payers have yet to issue a widely anticipated final decision on whether to reduce reimbursement 23-fold for SEPR Xopenex drug. We said last week that a delay beyond this week might bode well for the company, because it suggests that the Bush administration may be holding up the decision to consider the company's arguments for compromise." SEPR over all option implied volatility of 48 is near its 6-month average according to Track Data. Paul Foster
Related Categories
Analyst CommentsOptions
Stocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
